This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Leland Stanford Junior University, Howard Hughes Medical Institute, Other. Active years: 2002-2008.
Company Filing History:


Years Active: 2002-2008
Title: Gregory Thomas Ray: Innovator in Bifunctional Molecule Therapy
Introduction
Gregory Thomas Ray is a notable inventor based in Stanford, CA (US). He has made significant contributions to the field of therapeutic applications through his innovative work on bifunctional molecules. With a total of 3 patents, his research focuses on enhancing drug delivery systems.
Latest Patents
Ray's latest patents include groundbreaking methods for administering bifunctional molecules that contain a drug moiety and a presenter protein ligand for therapy. These patents describe the production of binary and tripartite complexes in a host, where the bifunctional molecule acts as a conjugate of a drug moiety and a presenter protein ligand. The methods involve administering an effective amount of the bifunctional molecule to the host, which binds to the presenter protein to produce a binary complex. This complex exhibits improved affinity, specificity, or selectivity compared to the corresponding free drug. The compositions and methods outlined in his patents have a wide range of therapeutic applications.
Career Highlights
Throughout his career, Gregory Thomas Ray has worked at Leland Stanford Junior University, where he has contributed to various research projects and innovations. His work has been instrumental in advancing the understanding of bifunctional molecules and their therapeutic potential.
Collaborations
Ray has collaborated with esteemed colleagues such as Roger Briesewitz and Gerald R Crabtree, further enhancing the impact of his research in the scientific community.
Conclusion
Gregory Thomas Ray's innovative work in the field of bifunctional molecules has paved the way for new therapeutic applications. His contributions continue to influence the landscape of drug delivery systems and therapeutic strategies.